Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin in Rheumatoid Arthritis Patients Treated with Methotrexate
NCT06641128Phase 4Not yet recruiting
- Sponsor
- Tanta University
- Start
- Oct 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of empagliflozin in rheumatoid arthritis (RA), sponsored by Tanta University. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
empagliflozin
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT06641128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06641128.